Vanguard Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-29,535,954
| Closed | -$26.2M | – | 4623 |
|
|
2022
Q4 | $26.2M | Buy |
29,535,954
+7,019,380
| +31% | +$9.31M | ﹤0.01% | 2498 |
|
|
2022
Q3 | $35.4M | Buy |
22,516,574
+1,620,150
| +8% | +$3.68M | ﹤0.01% | 2353 |
|
|
2022
Q2 | $42M | Buy |
20,896,424
+4,995,039
| +31% | +$8.64M | ﹤0.01% | 2277 |
|
|
2022
Q1 | $37.1M | Buy |
15,901,385
+208,655
| +1% | +$651K | ﹤0.01% | 2448 |
|
|
2021
Q4 | $73M | Buy |
15,692,730
+186,237
| +1% | +$1.16M | ﹤0.01% | 2143 |
|
|
2021
Q3 | $118M | Buy |
15,506,493
+1,376,502
| +10% | +$11.7M | ﹤0.01% | 1900 |
|
|
2021
Q2 | $137M | Buy |
14,129,991
+575,472
| +4% | +$4.58M | ﹤0.01% | 1823 |
|
|
2021
Q1 | $112M | Buy |
13,554,519
+1,244,652
| +10% | +$13.1M | ﹤0.01% | 1889 |
|
|
2020
Q4 | $84M | Buy |
12,309,867
+1,207,388
| +11% | +$9.7M | ﹤0.01% | 1921 |
|
|
2020
Q3 | $124M | Buy |
11,102,479
+1,334,442
| +14% | +$12.2M | ﹤0.01% | 1580 |
|
|
2020
Q2 | $61.3M | Buy |
9,768,037
+3,200,338
| +49% | +$12.3M | ﹤0.01% | 1904 |
|
|
2020
Q1 | $12.1M | Buy |
6,567,699
+111,004
| +2% | +$320K | ﹤0.01% | 2527 |
|
|
2019
Q4 | $21.8M | Buy |
6,456,695
+1,322,651
| +26% | +$3.15M | ﹤0.01% | 2496 |
|
|
2019
Q3 | $11M | Buy |
5,134,044
+332,712
| +7% | +$775K | ﹤0.01% | 2767 |
|
|
2019
Q2 | $12.8M | Buy |
4,801,332
+398,489
| +9% | +$1.43M | ﹤0.01% | 2718 |
|
|
2019
Q1 | $20.9M | Buy |
4,402,843
+791,161
| +22% | +$2.08M | ﹤0.01% | 2491 |
|
|
2018
Q4 | $8.67M | Sell |
3,611,682
-1,810,195
| -33% | -$5.91M | ﹤0.01% | 2835 |
|
|
2018
Q3 | $23.9M | Buy |
5,421,877
+925,542
| +21% | +$5.13M | ﹤0.01% | 2500 |
|
|
2018
Q2 | $32.4M | Buy |
4,496,335
+1,463,401
| +48% | +$9.95M | ﹤0.01% | 2350 |
|
|
2018
Q1 | $15.6M | Buy |
3,032,934
+626,473
| +26% | +$4.46M | ﹤0.01% | 2595 |
|
|
2017
Q4 | $9.14M | Buy |
2,406,461
+222,396
| +10% | +$579K | ﹤0.01% | 2866 |
|
|
2017
Q3 | $3.71M | Buy |
2,184,065
+253,541
| +13% | +$465K | ﹤0.01% | 3220 |
|
|
2017
Q2 | $3.86M | Buy |
1,930,524
+389,258
| +25% | +$760K | ﹤0.01% | 3182 |
|
|
2017
Q1 | $6.09M | Sell |
1,541,266
-35,751
| -2% | -$179K | ﹤0.01% | 2981 |
|
|
2016
Q4 | $7.73M | Buy |
1,577,017
+57,297
| +4% | +$344K | ﹤0.01% | 2854 |
|
|
2016
Q3 | $11.8M | Buy |
1,519,720
+551,797
| +57% | +$3.72M | ﹤0.01% | 2611 |
|
|
2016
Q2 | $5.42M | Sell |
967,923
-44,529
| -4% | -$285K | ﹤0.01% | 2938 |
|
|
2016
Q1 | $5.45M | Buy |
1,012,452
+145,228
| +17% | +$844K | ﹤0.01% | 2916 |
|
|
2015
Q4 | $7.55M | Buy |
867,224
+74,724
| +9% | +$630K | ﹤0.01% | 2789 |
|
|
2015
Q3 | $6.65M | Buy |
792,500
+42,678
| +6% | +$680K | ﹤0.01% | 2834 |
|
|
2015
Q2 | $13.2M | Buy |
749,822
+162,008
| +28% | +$2.08M | ﹤0.01% | 2535 |
|
|
2015
Q1 | $6.79M | Buy |
587,814
+155,604
| +36% | +$1.8M | ﹤0.01% | 2837 |
|
|
2014
Q4 | $4.35M | Buy |
432,210
+42,618
| +11% | +$216K | ﹤0.01% | 2969 |
|
|
2014
Q3 | $1.76M | Buy |
389,592
+15,391
| +4% | +$82.7K | ﹤0.01% | 3316 |
|
|
2014
Q2 | $2.53M | Buy |
374,201
+200,066
| +115% | +$1.51M | ﹤0.01% | 3160 |
|
|
2014
Q1 | $2.23M | Buy |
174,135
+163,095
| +1,477% | +$1.8M | ﹤0.01% | 3170 |
|
|
2013
Q4 | $89K | Buy |
+11,040
| New | +$97.1K | ﹤0.01% | 3844 |
|
Other funds holding SRNE
PP
OCM
OFA
CGA
LCM
STB
GA
HFRG
VFA
GBWM